Yi-te Hsu to Animals
This is a "connection" page, showing publications Yi-te Hsu has written about Animals.
Connection Strength
0.167
-
Nanoparticle delivery of HIF1a siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer. Cancer Lett. 2015 Apr 01; 359(1):65-74.
Score: 0.038
-
Complete activation of Bax by a single site mutation. Oncogene. 2007 Nov 01; 26(50):7092-102.
Score: 0.022
-
Distinct domains of Bcl-XL are involved in Bax and Bad antagonism and in apoptosis inhibition. Exp Cell Res. 2005 Oct 01; 309(2):316-28.
Score: 0.020
-
Differential immunoscreening identifies a glycosylation variant of the epidermal growth factor receptor in ME-180 cervical carcinoma cells. Hybridoma (Larchmt). 2005 Oct; 24(5):225-30.
Score: 0.020
-
Generation and characterization of monoclonal antibodies directed against the surface antigens of cervical cancer cells. Hybrid Hybridomics. 2004 Apr; 23(2):121-5.
Score: 0.018
-
Apoptosis modulatory activities of transiently expressed Bcl-2: roles in cytochrome C release and Bax regulation. Apoptosis. 2003 Dec; 8(6):617-29.
Score: 0.017
-
Generation and characterization of species-specific anti-Bcl-X(L) monoclonal antibodies. Hybrid Hybridomics. 2003 Apr; 22(2):91-5.
Score: 0.017
-
Inhibition of cytoplasmic p53 differentially modulates Ca(2+) signaling and cellular viability in young and aged striata. Exp Gerontol. 2014 Oct; 58:120-7.
Score: 0.009
-
Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling. Am J Physiol Heart Circ Physiol. 2010 Nov; 299(5):H1419-27.
Score: 0.007